NCT02421094View on ClinicalTrials.gov

Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 27, 2016

Study Completion Date

September 27, 2016

Conditions
Nonalcoholic Steatohepatitis
Interventions
DRUG

GR-MD-02

GM-MD-02 active

DRUG

Placebo

Placebo

Trial Locations (1)

78234

Brooke Army Medical Center, Fort Sam Houston

Sponsors
All Listed Sponsors
lead

Galectin Therapeutics Inc.

INDUSTRY